{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:33:38Z","timestamp":1788348818365,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002708","name":"Agence Universitaire de la Francophonie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004466","name":"Centre International de Recherches M\u00e9dicales de Franceville","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004466","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["PROT 0020\/2015\/SG\/CNE"],"award-info":[{"award-number":["PROT 0020\/2015\/SG\/CNE"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jgar.2021.03.003","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T13:37:57Z","timestamp":1616593077000},"page":"181-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["High prevalence of genotypes associated with sulfadoxine\/pyrimethamine resistance in the rural area of Fougamou, Gabon"],"prefix":"10.1016","volume":"25","author":[{"given":"Fleuramie Mirembou","family":"Boukoumba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Bernard","family":"Lekana-Douki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Blaise","family":"Matsiegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiella Nancy","family":"Moukodoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayola Akim","family":"Adegnika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine Lydie","family":"Oyegue-Liabagui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2021.03.003_bib0001","series-title":"World malaria report 2018","year":"2018"},{"key":"10.1016\/j.jgar.2021.03.003_bib0002","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM200101253440403","article-title":"A molecular marker for chloroquine-resistant falciparum malaria","volume":"344","author":"Djimd\u00e9","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2021.03.003_bib0003","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.tips.2006.09.005","article-title":"Transporters involved in resistance to antimalarial drugs","volume":"27","author":"Valderramos","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jgar.2021.03.003_bib0004","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1432-1033.1994.00397.x","article-title":"Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine","volume":"224","author":"Brooks","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jgar.2021.03.003_bib0005","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1073\/pnas.91.15.7149","article-title":"Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum","volume":"91","author":"Triglia","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jgar.2021.03.003_bib0006","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1073\/pnas.84.23.8360","article-title":"Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene","volume":"84","author":"Bzik","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jgar.2021.03.003_bib0007","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0035-9203(54)90085-1","article-title":"Resistance of East African varieties of Plasmodium falciparum to pyrimethamine","volume":"48","author":"Clyde","year":"1954","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jgar.2021.03.003_bib0008","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0035-9203(90)90246-B","article-title":"The epidemiology of drug-resistant malaria","volume":"84","author":"Bjorkman","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jgar.2021.03.003_bib0009","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-3156.2001.00792.x","article-title":"Plasmodium falciparum pfcrt andpfmdr1 polymorphisms are associated with thepfdhfr N108 pyrimethamine-resistance mutation in isolates from Ghana","volume":"6","author":"Mockenhaupt","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jgar.2021.03.003_bib0010","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","article-title":"Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria","volume":"85","author":"Peterson","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jgar.2021.03.003_bib0011","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0166-6851(94)00207-4","article-title":"Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum","volume":"69","author":"Basco","year":"1995","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.jgar.2021.03.003_bib0012","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1128\/AAC.42.1.164","article-title":"Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain","volume":"42","author":"Nzila-Mounda","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.03.003_bib0013","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.94.25.13944","article-title":"Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum","volume":"94","author":"Triglia","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jgar.2021.03.003_bib0014","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1475-2875-7-115","article-title":"Rapid increase of Plasmodium falciparum dhfr\/dhps resistant haplotypes, after the adoption of sulphadoxine\u2013pyrimethamine as first line treatment in 2002, in southern Mozambique","volume":"7","author":"Enosse","year":"2008","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2021.03.003_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2875-8-89","article-title":"A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria","volume":"8","author":"Picot","year":"2009","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2021.03.003_bib0016","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0035-9203(02)90345-7","article-title":"Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo","volume":"96","author":"Borrmann","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jgar.2021.03.003_bib0017","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/1471-2334-12-307","article-title":"In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon","volume":"12","author":"Zatra","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2021.03.003_bib0018","first-page":"68","article-title":"Concurrent chloroquine and Fansidar resistance of Plasmodium falciparum: an imported case from Gabon","volume":"40","author":"Burchard","year":"1988","journal-title":"Trop Geogr Med"},{"key":"10.1016\/j.jgar.2021.03.003_bib0019","first-page":"214","article-title":"Drug sensitivity of Plasmodium falciparum in Gabon. Activity correlations between various antimalarials","volume":"45","author":"Winkler","year":"1994","journal-title":"Trop Med Parasitol"},{"key":"10.1016\/j.jgar.2021.03.003_bib0020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0035-9203(00)90272-4","article-title":"Sulfadoxine\u2013pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children","volume":"94","author":"Deloron","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jgar.2021.03.003_bib0021","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/AAC.47.1.231-237.2003","article-title":"Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine\u2013pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children","volume":"47","author":"Aubouy","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.03.003_bib0022","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0001-706X(01)00084-5","article-title":"Molecular analysis of DHFR and DHPS genes in P. falciparum clinical isolates from the Haut-Ogoou\u00e9 region in Gabon","volume":"78","author":"Mawili-Mboumba","year":"2001","journal-title":"Acta Trop"},{"key":"10.1016\/j.jgar.2021.03.003_bib0023","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/dkg294","article-title":"DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine\u2013pyrimethamine treatment efficacy","volume":"52","author":"Aubouy","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.03.003_bib0024","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4269\/ajtmh.2007.77.418","article-title":"Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon","volume":"77","author":"Ramharter","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.jgar.2021.03.003_bib0025","article-title":"Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment","author":"Radeva-Petrova","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgar.2021.03.003_bib0026","article-title":"Increased prevalence of mutant allele Pfdhps 437G and Pfdhfr triple mutation in Plasmodium falciparum isolates from a rural area of Gabon, three years after the change of malaria treatment policy","volume":"2016","author":"Ndong Ngomo","year":"2016","journal-title":"Malar Res Treat"},{"key":"10.1016\/j.jgar.2021.03.003_bib0027","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12889-015-1456-4","article-title":"No evidence of decline in malaria burden from 2006 to 2013 in a rural province of Gabon: implications for public health policy","volume":"15","author":"Assele","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jgar.2021.03.003_bib0028","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4269\/ajtmh.15-0751","article-title":"Co-circulation of Plasmodium and bacterial deoxyribonucleic acids in blood of febrile and afebrile children from urban and rural areas in Gabon","volume":"95","author":"Mourembou","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2021.03.003_bib0029","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12936-016-1469-1","article-title":"Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr1 and Pfcrt genotypes from symptomatic children","volume":"15","author":"Maghnedji-Nzondo","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2021.03.003_bib0030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/1475-2875-12-412","article-title":"Malaria in pregnancy in rural Gabon: a cross-sectional survey on the impact of seasonality in high-risk groups","volume":"12","author":"Jackle","year":"2013","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2021.03.003_bib0031","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4269\/ajtmh.2001.65.599","article-title":"Comparison of methods for the rapid laboratory assessment of children with malaria","volume":"65","author":"Planche","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2021.03.003_bib0032","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.meegid.2011.01.003","article-title":"Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether\u2013lumefantrine and artesunate\u2013mefloquine","volume":"11","author":"Lekana-Douki","year":"2011","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.jgar.2021.03.003_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/expr.1998.4274","article-title":"Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion","volume":"89","author":"Duraisingh","year":"1998","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.jgar.2021.03.003_bib0034","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3184\/003685002783238906","article-title":"Resistance to antifolates in Plasmodium falciparum, the causative agent of tropical malaria","volume":"85","author":"Warhurst","year":"2002","journal-title":"Sci Prog"},{"key":"10.1016\/j.jgar.2021.03.003_bib0035","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s12936-015-1035-2","article-title":"Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine\u2013pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen","volume":"14","author":"Bamaga","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2021.03.003_bib0036","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2147\/IDR.S160164","article-title":"Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014","volume":"11","author":"Voumbo-Matoumona","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2021.03.003_bib0037","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1475-2875-8-106","article-title":"Chloroquine resistance before and after its withdrawal in Kenya","volume":"8","author":"Mwai","year":"2009","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2021.03.003_bib0038","doi-asserted-by":"crossref","first-page":"e4569","DOI":"10.1371\/journal.pone.0004569","article-title":"High resistance of Plasmodium falciparum to sulphadoxine\/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at codon 581","volume":"4","author":"Gesase","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2021.03.003_bib0039","first-page":"51","article-title":"Antimalarial drug resistance","volume":"2010","author":"Pradines","year":"2010","journal-title":"Rev Francoph Lab"},{"key":"10.1016\/j.jgar.2021.03.003_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126943","article-title":"Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of sulfadoxine\u2013pyrimethamine in North Western Ethiopia","volume":"10","author":"Tessema","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2021.03.003_bib0041","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jac\/dkn482","article-title":"Indigenous evolution of Plasmodium falciparum pyrimethamine resistance multiple times in Africa","volume":"63","author":"Mita","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.03.003_bib0042","first-page":"113","article-title":"Molecular analysis of markers associated with chloroquine and sulfadoxine\/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Cote-d'Ivoire by the time of artemisinin-based combination therapy adoption in 2005","volume":"5","author":"Ako","year":"2015","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2021.03.003_bib0043","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1475-2875-9-68","article-title":"Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates","volume":"9","author":"Dlamini","year":"2010","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2021.03.003_bib0044","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4269\/ajtmh.2009.80.523","article-title":"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene","volume":"80","author":"Alifrangis","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2021.03.003_bib0045","doi-asserted-by":"crossref","first-page":"996","DOI":"10.4269\/ajtmh.2012.12-0202","article-title":"Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine\u2013pyrimethamine 5 years after the change of malaria treatment policy in Ghana","volume":"87","author":"Duah","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2021.03.003_bib0046","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1475-2875-7-31","article-title":"Sulphadoxine\/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide national policy","volume":"7","author":"Nsimba","year":"2008","journal-title":"Malar J"},{"key":"10.1016\/j.jgar.2021.03.003_bib0047","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/infdis\/jiu836","article-title":"The A581G mutation in the gene encoding Plasmodium falciparum dihydropteroate synthetase reduces the effectiveness of sulfadoxine\u2013pyrimethamine preventive therapy in Malawian pregnant women","volume":"211","author":"Gutman","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2021.03.003_bib0048","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12936-016-1358-7","article-title":"Low-grade sulfadoxine\u2013pyrimethamine resistance in Plasmodium falciparum parasites from Lubango","volume":"15","author":"Kaingona-Daniel","year":"2016","journal-title":"Angola. Malar J"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521000709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521000709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:58:49Z","timestamp":1761991129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716521000709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":48,"alternative-id":["S2213716521000709"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2021.03.003","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High prevalence of genotypes associated with sulfadoxine\/pyrimethamine resistance in the rural area of Fougamou, Gabon","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2021.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}